Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Forest signs agreement with Merckle for U.S. development and marketing of ML-3000

April 14, 2000

Japanese investigators explore uses for new chymase inhibitor SUN-C8257

April 12, 2000

Amarillo Biosciences reports phase III results for interferon alfa in Sjogren's syndrome

April 12, 2000

Prosorba Column launched in Europe for RA

April 11, 2000

Glaxo Wellcome continues research on formamides as inhibitors of MMPs and/or TNF-alpha release

April 11, 2000

Psoriatic arthritis patients sought for clinical trial

April 10, 2000

New class of matrix metalloproteinase inhibitors in development by AstraZeneca

April 10, 2000

Formamide compounds from Glaxo Wellcome inhibit TNF-alpha release and MMP activity

April 10, 2000

Alexion to commence phase Ib pilot study of 5G1.1 in pemphigoid patients

April 7, 2000

AstraZeneca develops new class of MMP inhibitors with selectivity for MMP-13, MMP-9

April 7, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
Saniona reports preclinical data for SAN-2668
BioWorld Science
Saniona AB has presented preclinical data and its clinical development strategy for its lead clinical candidate, SAN-2668, which is a GABA-A receptor positive...
CC-3 antibody shows antitumoral activity in penile cancer
BioWorld Science
Advanced penile cancer (PeCa) is a rare cancer affecting the genitourinary tract with a 5-year survival rate of about 10% when metastatic. First-line therapies...